Medium Chain Triglycerides Market Report 2026

The medium chain triglycerides market size has grown strongly in recent years. It will grow from $2.24 billion in 2025 to $2.45 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to growth of dietary supplement consumption, increased awareness of ketogenic diets, expansion of functional food applications, availability of coconut and palm oil feedstocks, rising health and wellness spending.

The medium chain triglycerides market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for plant-based functional ingredients, expansion of personalized nutrition products, growing use in pharmaceutical formulations, rising focus on sustainable sourcing, increasing adoption in clinical nutrition. Major trends in the forecast period include increasing use in nutraceutical and keto products, rising demand for coconut-based mcts, growing adoption in sports nutrition, expansion of powdered mct formulations, enhanced focus on clean and organic sourcing.

The rising prevalence of obesity is expected to drive the growth of the medium-chain triglycerides (MCTs) market. Obesity is a chronic and complex condition characterized by excessive body fat accumulation, negatively impacting health. Factors contributing to obesity include an increase in health-conscious behaviors, unhealthy eating habits, and a lack of exercise. Medium-chain triglycerides are quickly absorbed and transported directly to the liver, where they are rapidly converted into energy (ketones) instead of being stored as fat. This process can enhance metabolic rate and energy expenditure more effectively than long-chain fatty acids (LCTs). For example, in March 2023, the World Heart Foundation, a global cardiovascular community based in Switzerland, reported that approximately 2.3 billion adults and children worldwide are obese or overweight. It is estimated that this number will rise to 2.7 billion by 2025. Consequently, the increasing prevalence of obesity is fueling the demand for medium-chain triglycerides.

Leading companies in the medium chain triglycerides (MCT) market are focusing on developing advanced, health-oriented products, such as innovative MCT chocolates, to meet growing industry demands. MCT chocolate serves as a versatile, nutritious ingredient for health-conscious consumers, finding applications in snacks, smoothies, coffee, and baked goods. For example, in September 2024, Japan-based Morinaga Milk launched an MCT chocolate designed to support weight management, specifically catering to individuals mindful of their health and dietary goals. This new product offers the familiar taste of chocolate while providing the benefits of MCTs, which are known to aid in fat oxidation and boost energy levels. This launch reflects Morinaga Milk's commitment to creating functional foods that align with consumers’ health and convenience needs.

In July 2023, Novartis AG, a Switzerland-based pharmaceutical company, acquired DTx Pharma for an undisclosed amount. This acquisition aims to bolster Novartis' neuroscience pipeline and RNA-based therapeutic expertise by incorporating DTx Pharma’s FALCON platform, designed to improve siRNA delivery beyond the liver. A primary focus of this integration is the development of DTx-1252 for Charcot-Marie-Tooth disease type 1A. DTx Pharma, a U.S.-based biotech startup in the preclinical stage, specializes in advancing RNA therapeutics with its proprietary FALCON platform, which leverages medium-chain triglycerides (MCTs) for enhanced therapeutic delivery.

Major companies operating in the medium chain triglycerides market are Nestle Health Science S.A., BASF SE, Wilmar International Ltd., ABF Ingredients, DuPont de Nemours Inc., Musim Mas Group, Lonza Group AG, The Nisshin OilliO Group Ltd., IOI Oleochemical, Stepan Company, Croda International Plc, KLK Oleo, Sternchemie GmbH & Co. KG (Stern-Wywiol Gruppe GmbH & Co. KG), Oleon NV, Jarrow Formulas Inc., ABITEC, Connoils LLC, Acme-Hardesty (Jacob Stern & Sons Inc.), Barlean's, CREMER OLEO GmbH & Co. KG, Henry Lamotte Oils GmbH.

North America was the largest region in the medium chain triglycerides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medium chain triglycerides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medium chain triglycerides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The medium-chain triglycerides market consists of sales of caproic acid (hexanoic acid), caproic acid (hexanoic acid), capric acid (decanoic acid), and lauric acid (dodecanoic acid). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.